Preliminary Q1 2025 Rxsight Inc Earnings Call Transcript
Key Points
- RxSight Inc (RXST) reported a 28% increase in preliminary first-quarter revenue compared to the same period last year.
- The company sold 73 Light Delivery Devices (LDDs) in Q1, marking an 11% increase from the previous year.
- RxSight Inc (RXST) achieved a 36% increase in Light Adjustable Lenses (LALs) sales compared to Q1 2024.
- The company received European regulatory approval for its LDD and LAL, expanding its potential market reach.
- Customer satisfaction is at an all-time high of 97%, indicating strong acceptance of RxSight's adjustable technology.
- RxSight Inc (RXST) revised its full-year revenue guidance downward from $185-$197 million to $160-$175 million.
- The company experienced a sequential 6% decline in revenue from Q4 2024 to Q1 2025.
- There was a notable decline in LALs per LDD per month, indicating reduced utilization rates.
- The premium IOL market has softened, impacting RxSight Inc (RXST)'s sales and growth projections.
- Macroeconomic factors, including declines in the S&P and NASDAQ, have negatively affected consumer sentiment and decision-making for premium IOL procedures.
Thank you for standing by, and welcome to the RxSight conference call. (Operator instructions)
I would now like to turn the call over to Oliver Morrisvich, VP of Investor Relations. Please go ahead
Thank you, operator. Presenting today are RxSight President and Chief Executive Officer, Dr. Ron Kurtz; and Chief Financial Officer, Shelley Thunen. Yesterday evening, RxSight released preliminary revenue results for the three months ending March 31, 2025, and revised full year guidance. A copy of the press release is available on the company's website.
Before we begin, I would like to inform you that comments and responses to questions during today's call reflect management's views as of today, April 3, 2025, and will include forward-looking and opinion statements, including predictions, estimates, plans, expectations and other information. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties.
These risks and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
